The possible effect of long-term high plasma levels of phenytoin on mortality after acute myocardial infarction

[1]  H. Karpman,et al.  Phenytoin after recovery from myocardial infarction. , 1972, Lancet.

[2]  R. Prineas,et al.  Interaction between phenytoin and the benzodiazepines. , 1971, British medical journal.

[3]  F. Vajda.  THE VALUE OF PHENYTOIN PLASMA LEVELS IN THE TREATMENT OF EPILEPSY , 1970, The Medical journal of Australia.

[4]  D. Davies.  Cytochrome P-450 and drug oxidation. , 1969, The Biochemical journal.

[5]  M. Klein,et al.  Pathogenesis, Prevention, and Treatment of Arrhythmias in Myocardial Infarction , 1969 .

[6]  J. Bigger,et al.  Relationship Between the Plasma Level of Diphenylhydantoin Sodium and Its Cardiac Antiarrhythmic Effects , 1968, Circulation.

[7]  H. J. Zeft,et al.  Diphenylhydantoin therapy in experimental myocardial infarction. , 1968, The Journal of pharmacology and experimental therapeutics.

[8]  J. Wallace.  Microdetermination of diphenylhydantoin in biological specimens by ultraviolet spectrophotometry. , 1968, Analytical chemistry.

[9]  W. Austen,et al.  Cardiac and peripheral vascular effects of diphenylhydantoin sodium. , 1966, The American journal of cardiology.

[10]  H. Kutt,et al.  DIPHENYLHYDANTOIN METABOLISM, BLOOD LEVELS, AND TOXICITY. , 1964, Archives of neurology.

[11]  P. Stensrud,et al.  Serum Phenytoin Determinations in Epileptics , 1964, Epilepsia.

[12]  E. Loeser.  Studies on the metabolism of diphenylhydantoin (Dilantin) , 1961, Neurology.

[13]  F. Buchthal,et al.  Aspects of the Pharmacology of Phenytoin (Dilantin®) and Phenobarbital Relevant to their Dosage in the Treatment of Epilepsy , 1959, Epilepsia.

[14]  F. Ederer,et al.  Maximum utilization of the life table method in analyzing survival. , 1958, Journal of chronic diseases.

[15]  J. Haynes,et al.  Studies of diphenylhydantoin metabolism. , 1965, Transactions of the American Neurological Association.

[16]  T. Butler.  The metabolic conversion of 5, 5-diphenyl hydantoin to 5-(p-hydroxyphenyl)-5-phenyl hydantoin. , 1957, The Journal of pharmacology and experimental therapeutics.